Therapeutic potential of adipose derived stromal cells for major skin inflammatory diseases.
Ontology highlight
ABSTRACT: Inflammatory skin diseases like psoriasis and atopic dermatitis are chronic inflammatory skin conditions continuously under investigation due to increased prevalence and lack of cure. Moreover, long-term treatments available are often associated with adverse effects and drug resistance. Consequently, there is a clear unmet need for new therapeutic approaches. One promising and cutting-edge treatment option is the use of adipose-derived mesenchymal stromal cells (AD-MSCs) due to its immunomodulatory and anti-inflammatory properties. Therefore, this mini review aims to highlight why adipose-derived mesenchymal stromal cells are a potential new treatment for these diseases by summarizing the pre-clinical and clinical studies investigated up to date and addressing current limitations and unres
SUBMITTER: Galera MR
PROVIDER: S-EPMC10921940 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA